INTECH INVESTMENT MANAGEMENT LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1086318 WEST PALM BEACH, FL

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$2,015,082

-$1,043,008 QoQ

Shares Held

38,984

-36.6% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	311,871	$36,866,270
2	TEVA	Teva Pharmaceutical Industries Ltd	478,939	$14,425,641
3	UTHR	UNITED THERAPEUTICS Corp	20,744	$12,300,776
4	NBIX	Neurocrine Biosciences Inc	86,315	$11,371,137
5	LNTH	Lantheus Holdings, Inc.	44,826	$3,400,052
6	INDV	Indivior Pharmaceuticals, Inc.	88,945	$2,711,043
7	ALKS	Alkermes plc.	60,967	$2,155,793
8	SUPN	Supernus Pharmaceuticals, Inc. This page	38,984	$2,015,082

All Filings in SUPN

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,015,082	38,984	-36.6%	Shares	Sole	2026-05-08
2025-12-31	$3,058,090	61,531	+72.3%	Shares	Sole	2026-02-10
2025-09-30	$1,706,246	35,703	-17.2%	Shares	Sole	2025-11-12
2025-06-30	$1,358,638	43,104	+20.3%	Shares	Sole	2025-08-08
2025-03-31	$1,173,367	35,828	+26.4%	Shares	Sole	2025-05-20
2024-12-31	$1,025,208	28,352	+115.4%	Shares	Sole	2025-02-11
2024-09-30	$410,359	13,161	+16.2%	Shares	Sole	2024-11-08
2024-06-30	$302,890	11,323	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.